TY - JOUR
KW - Adult
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Combined Modality Therapy
KW - Counseling
KW - Follow-Up Studies
KW - Heroin Dependence/rehabilitation
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/rehabilitation
KW - Prescription Drug Misuse
KW - Addiction
KW - Follow-up
KW - opioid use disorder
KW - outcome
KW - Prescription opioids
KW - treatment
AU - R. D. Weiss
AU - V. Rao
A1 - 
AD - Division of Alcohol and Drug Abuse, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: rweiss@mclean.harvard.edu.; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Partners HealthCare Addiction Psychiatry Fellowship, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: vinod.rao@mgh.harvard.edu.
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CY - Ireland
JF - Drug and alcohol dependence
M1 - Journal Article
PB - The Author(s). Published by Elsevier B.V
PP - Ireland
PY - 2017
SN - 1879-0046; 0376-8716
SP - S48
EP - S54
EP - 
T1 - The Prescription Opioid Addiction Treatment Study: What have we learned
T2 - Drug and alcohol dependence
TI - The Prescription Opioid Addiction Treatment Study: What have we learned
U1 - Opioids & Substance Use
U2 - 28363320
VL - 173 Suppl 1
VO - 1879-0046; 0376-8716
Y1 - 2017
Y2 - Apr 1
ER -